Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Hamadani

Showing results (131-140 of 460) with videos related to

Pageof 46
Sort By:
Haematologica|February 3, 2022
Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefitMatthew Mei, Mehdi Hamadani, Kwang W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2018
Pharmacokinetics of High-Dose Propylene Glycol-Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell TransplantationBinod Dhakal, Anita D'Souza, Arjun Lakshman, et al.
Leukemia & Lymphoma|November 26, 2019
Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host diseaseSaurabh Chhabra, James H Jerkins, John E Conto, et al.
Seminars in Hematology|January 29, 2014
Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin lymphomasMehdi Hamadani, Sarah M Abu Kar, Saad Z Usmani, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosisAnita D'Souza, Kathryn Flynn, Saurabh Chhabra, et al.
Blood Reviews|March 11, 2022
Reality check: Real-world evidence to support therapeutic development in hematologic malignanciesBenjamin A Derman, Andrew J Belli, Minoo Battiwalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donorBeth Christian, Weiqiang Zhao, Mehdi Hamadani, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese PatientsR Brigg Turner, Aaron Cumpston, Michael Sweet, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2022
Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphomaMarie Toukam, Jens Wuerthner, Karin Havenith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Evaluation of the Pharmacokinetics and Efficacy of a Busulfan Test Dose in Adult Patients Undergoing Myeloablative Hematopoietic Cell TransplantationElizabeth Weil, Felicia Zook, Carolyn Oxencis, et al.
Pageof 46

Showing results (131-140 of 460) with videos related to

Sort By:
Pageof 46
Haematologica|February 3, 2022
Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefitMatthew Mei, Mehdi Hamadani, Kwang W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2018
Pharmacokinetics of High-Dose Propylene Glycol-Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell TransplantationBinod Dhakal, Anita D'Souza, Arjun Lakshman, et al.
Leukemia & Lymphoma|November 26, 2019
Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host diseaseSaurabh Chhabra, James H Jerkins, John E Conto, et al.
Seminars in Hematology|January 29, 2014
Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin lymphomasMehdi Hamadani, Sarah M Abu Kar, Saad Z Usmani, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosisAnita D'Souza, Kathryn Flynn, Saurabh Chhabra, et al.
Blood Reviews|March 11, 2022
Reality check: Real-world evidence to support therapeutic development in hematologic malignanciesBenjamin A Derman, Andrew J Belli, Minoo Battiwalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donorBeth Christian, Weiqiang Zhao, Mehdi Hamadani, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese PatientsR Brigg Turner, Aaron Cumpston, Michael Sweet, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2022
Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphomaMarie Toukam, Jens Wuerthner, Karin Havenith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Evaluation of the Pharmacokinetics and Efficacy of a Busulfan Test Dose in Adult Patients Undergoing Myeloablative Hematopoietic Cell TransplantationElizabeth Weil, Felicia Zook, Carolyn Oxencis, et al.
Pageof 46